Skip to content

safety and efficacy of ciprofol and propofol in painless induced abortion

safety and efficacy of ciprofol and propofol in painless induced abortion

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084520
Enrollment
Unknown
Registered
2024-05-20
Start date
2023-01-13
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early pregnancy

Interventions

ciprofol group :ciprofol anesthesia

Sponsors

Second affiliated hospital of Shantou university medical college
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Having the indications of painless induced abortion and tolerance, American Society of Anesthesiologists (ASA) grade I and II, age 18-45 years, 18 kg/m^2=BMI<30 kg/m^2, normal blood routine, coagulation function, liver and kidney function and electrocardiogram.

Exclusion criteria

Exclusion criteria: Previous history of allergy to narcotic drugs, contraindicated evidence; Patients with severe organ dysfunction such as heart, liver and kidney; People with a history of chronic pain and long-term use of opioids; People with speech, hearing and mental disabilities; Patients deemed unsuitable for clinical study.

Design outcomes

Primary

MeasureTime frame
Success rate of anesthesia;Perioperative adverse event rate;

Secondary

MeasureTime frame
mean arterial pressure;Induction time of anesthesia;Operation time;Recovery time of anesthesia;Total drug dosage;Blood loss of operative;post-operative contraction pain;satisfaction of surgeons and patients;

Countries

China

Contacts

Public ContactChen Lu

Second affiliated hospital of Shantou university medical college

chenlu200505399@163.com+86 135 9287 4918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026